Researchers have devised a blood-based test of gene activity that can predict an individual’s level of aspirin resistance.
Until now, doctors have not been able to explain why patients vary in levels of aspirin resistance.
By monitoring gene activity patterns, the researchers discovered signature profiles that showed responsiveness. They could also be used to predict risk of heart attack.
The findings may lead to a standardised blood test to identify if aspirin is suitable prior to prescription.Read more at Duke University